Insitro

Insitro Raises $400M in Series D

Insitro has successfully raised $400M in a Series D at a $2.8B valuation led by Blackstone, Canada Pension Plan Investment Board, Arch Venture Partners, Foresite Capital, GV, Andreessen Horowitz.

Company Overview

Insitro is a Biotech company headquartered in 279 East Grand Avenue, South San Francisco, CA 94080, founded in 2018 with 300+ employees.

Machine learning for drug discovery

Fundraising Details

• Amount Raised: $400M
• Round Type: Series D
• Valuation: $2.8B
• Date: 2024-09-08
• Investors: Blackstone, Canada Pension Plan Investment Board, Arch Venture Partners, Foresite Capital, GV, Andreessen Horowitz

About Insitro

Machine learning for drug discovery The company is positioned in the Biotech sector, serving a growing market with innovative solutions.

Key Information

• Headquarters: 279 East Grand Avenue, South San Francisco, CA 94080
• Founded: 2018
• Team Size: 300+
• Industry: Biotech

What This Means

This funding round demonstrates strong investor confidence in Insitro's vision and execution. The capital will likely be used to:

• Scale Operations: Expand the team and operational capacity
• Product Development: Enhance existing products and develop new features
• Market Expansion: Enter new markets and strengthen presence in existing ones
• Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Insitro's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $2.8B valuation marks an important milestone for Insitro, positioning the company among notable players in the Biotech industry.

Looking Ahead

With this new capital, Insitro is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2024-09-08. For more information about Insitro, visit their headquarters at 279 East Grand Avenue, South San Francisco, CA 94080.